Calcium-channel blockers and risk of cancer

Lancet

Volumn 349, Issue 9051, 1997, Pages 525-528

  Jick, Hershel ^a   Jick, Susan ^a   Derby, Laura E ^a   Vasilakis, Catherine ^a   Myers, Marian Wald ^a   Meier, Christoph R ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER; CANCER RISK; CONTROLLED STUDY; DATA BASE; DRUG SURVEILLANCE PROGRAM; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031050146     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80084-0     Document Type: Article

References (14)

1. Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9: 695-99.
2. Jick H, Jick SS, Derby LE. Validation of information recorded on general-practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302: 766-68.
3. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992; 1: 347-49.
4. Jick H, Hall GC, Dean AD, Jick SS, Derby LE. A comparison of the risk of hypoglycemia between users of human and animal insulins 1: experience in the United Kingdom. Pharmacotherapy 1990; 10: 395-97.
5. Van Staa T, Abenheim L. The quality of information on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994; 3: 15-21.
6. García Rodríguez LA, Jick H. Comparison of the risk of gynaecomastia associated with cimetidine, omeprazole and other antiulcer medications. BMJ 1994; 308: 503-06.
7. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
8. Jick SS, Dean AD, Jick H. Antidepressants and fatal suicide. BMJ 1995; 310: 215-18.
9. García Rodríguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with non-steroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994; 154: 311-16.
10. García Rodríguez LA, Jick H. The risk of upper gastrointestinal bleeding and/or perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
11. Derby LE, Jick H, Henry DA, Dean AD. Cholestatic hepatitis associated with flucloxacillin. Med J Aust 1993; 158: 596-600.
12. Jick H, Derby LE. A large population-based follow-up study of trimethoprim/sulfamethoxazole, trimethoprim, and cephalexin users for certain uncommon, serious drug toxicity. Pharmacotherapy 1995; 15: 428-32.
13. Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996; 16 (3): 321-26.
14. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-97.